tiprankstipranks
Trending News
More News >
Citius Oncology, Inc. (CTOR)
NASDAQ:CTOR
US Market

Citius Oncology (CTOR) Income Statement

Compare
130 Followers

Citius Oncology Income Statement

Last quarter (Q1 2026), Citius Oncology's total revenue was $3.94M, an increase of Infinity% from the same quarter last year. In Q1, Citius Oncology's net income was $-5.53M. See Citius Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 23.52M$ 20.57M$ 12.12M$ 9.71M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 9.71M
EBITDA
$ -23.49M$ -20.57M$ -12.12M$ 0.00
Operating Income
$ -23.52M$ -20.57M$ -12.12M$ -9.71M
Other Income/Expenses
$ -181.66K$ 0.00$ 0.00$ 0.00
Pretax Income
$ -23.70M$ -20.57M$ -12.12M$ -9.71M
Net Income
$ -24.76M$ -21.15M$ -12.70M$ -10.87M
Per Share Metrics
Basic EPS
$ -0.34$ -0.30$ -0.19$ -0.08
Diluted EPS
$ -0.34$ -0.30$ -0.19$ -0.08
Weighted Average Shares Outstanding
73.27M 71.55M 89.48M 90.16M
Weighted Average Shares Outstanding (Diluted)
73.27M 71.55M 89.48M 90.16M
Currency in USD

Citius Oncology Earnings and Revenue History